Market revenue in 2023 | USD 23.3 million |
Market revenue in 2030 | USD 32.5 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Oncology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.56% in 2023. Horizon Databook has segmented the Denmark point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Population Review, in 2022, Denmark was ranked fifth globally in terms of number of cancer cases. In Denmark, 334.9 people per 100,000 had cancer in 2020. Similarly, according to a recent article published by Informa UK Limited, around 250,000 people in Denmark were estimated to have diabetes, which amounted to 4.5% of the country's total population.
Since 1995, there has been a 2.5-fold increase in the prevalence of recognized diabetes, most likely due to increased diabetes incidence & diagnostic efforts. Increasing diagnosis in the country and growing awareness about disease diagnosis among people are expected to create growth opportunities in the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Denmark point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account